Skip to content

A clinical trial to compare the effect of a drug dexmedetomidine when given intramuscularly and in nerve block in patients receiving anaesthesia for forearm and hand surgeries

Comparison of dexmedetomidine in ultrasound guided supraclavicular brachial plexus block versus intramuscular administration in upper limb surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033190
Enrollment
60
Registered
2021-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: im dexmedetomidine: Patient will be given dexmedetomidine 1 mcg/kg intramuscularly on the same side of the nerve block Intervention2: perineural dexmedetomidine: Patient will be given s

Sponsors

Sanjana S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients undergoing elective and emergency upper limb surgeries under ultrasound-guided supraclavicular brachial plexus block with the American Society of Anaesthesiologists (ASA) physical status 1 and 2

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. History of allergic medications used in the study. 3. Patients with difficulty in communication. 4. Underlying conditions- bleeding disorders, local infection, existing brachial plexus deficits. 5. History of treatment for a chronic pain condition/ psychiatric disorder. 6. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory blockade Onset and duration of motor blockadeTimepoint: From the time of administration of study drug- every 5 minutes till 30 minutes, every 30 minutes till 2 hours, every 4 hours till 12 hours and then every 6 hours up to 24 hours.

Secondary

MeasureTime frame
Time taken for rescue analgesia Sedative effect Overall patient satisfaction.Timepoint: From the time of administration of study drug- every 5 minutes till 30 minutes, every 30 minutes till 2 hours, every 4 hours till 12 hours and then every 6 hours up to 24 hours.

Countries

India

Contacts

Public ContactSanjana S

Kasturba Medical College, Manipal

abhi.rao@manipal.edu9886118906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026